Nionyx Bio

Nephrogen

This biotechnology company develops artificial intelligence-driven gene therapies to treat kidney and pancreatic diseases for patients with genetic conditions.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Purespring

Purespring develops gene therapies targeting podocyte cells to treat chronic kidney diseases for patients with conditions such as IgA nephropathy and Alport syndrome.

Helex

This biotechnology company develops gene editing therapeutics and lipid nanoparticle delivery platforms for patients suffering from genetic kidney diseases.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.

Axovia Therapeutics

The company develops gene therapies for patients with ciliopathies, specifically targeting rare genetic conditions like Bardet-Biedl Syndrome to treat blindness and obesity.

ABIONYX Pharma

The company develops recombinant HDL-based biotherapies for patients with sepsis, renal diseases, and ophthalmological conditions.